Ibalgin Rapidcaps

Ibuprofen, the active ingredient in Ibalgin Rapidcaps, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as a capsule for oral use. It treats pain, fever and inflammation in adults and children as appropriate.

GNH USA supplies Ibalgin Rapidcaps as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibalgin Rapidcaps contains ibuprofen, an NSAID that reduces prostaglandin‑mediated processes in the body. It is indicated for several common conditions: - Pain: provides relief of mild to moderate nociceptive pain such as headache, dental or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infectious or inflammatory states. - Inflammation: diminishes swelling and redness in conditions like sprains, strains or minor arthritic episodes.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or mild vomiting - Headache - Dizziness - Transient rash or itching

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Acute renal impairment or failure - Severe allergic reactions including anaphylaxis - Hepatic injury or elevated liver enzymes - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Increased risk of cardiovascular thrombotic events

Before initiating therapy, consider the following safety measures: - Assess renal function: avoid use in patients with severe renal impairment. - Use the lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Caution with anticoagulants: monitor for enhanced bleeding risk. - Monitor gastrointestinal risk: consider gastro‑protective agents in high‑risk individuals. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ibuprofen can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened risk of ulceration or bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Lithium: ibuprofen may raise lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding tendency.